{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:00:42Z","timestamp":1791000042037,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.vaccine.2006.11.017","type":"journal-article","created":{"date-parts":[[2006,11,28]],"date-time":"2006-11-28T15:30:53Z","timestamp":1164727853000},"page":"1814-1823","source":"Crossref","is-referenced-by-count":155,"title":["Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge"],"prefix":"10.1016","volume":"25","author":[{"given":"Jay W.","family":"Hooper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph W.","family":"Golden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony M.","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2006.11.017_bib1","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/JVI.78.9.4433-4443.2004","article-title":"Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox","volume":"78","author":"Hooper","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2006.11.017_bib2","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-138-6-200303180-00014","article-title":"Evaluation of 21st-century risks of smallpox vaccination and policy options","volume":"138","author":"Lane","year":"2005","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.vaccine.2006.11.017_bib3","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nm1261","article-title":"Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challenge","volume":"11","author":"Edghill-Smith","year":"2005","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.vaccine.2006.11.017_bib4","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1099\/0022-1317-83-12-2915","article-title":"The formation and function of extracellular enveloped vaccinia virus","volume":"83","author":"Smith","year":"2002","journal-title":"Gen Virol"},{"key":"10.1016\/j.vaccine.2006.11.017_bib5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/viro.1999.0096","article-title":"DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge","volume":"266","author":"Hooper","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2006.11.017_bib6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0042-6822(02)00038-7","article-title":"Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates","volume":"306","author":"Hooper","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2006.11.017_bib7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/viro.1998.9516","article-title":"Neutralizing and protective antibodies directed against vaccinia virus envelope antigens","volume":"254","author":"Galmiche","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2006.11.017_bib8","doi-asserted-by":"crossref","first-page":"633","DOI":"10.4049\/jimmunol.175.2.633","article-title":"DNA vaccines: progress and challenges","volume":"175","author":"Donnelly","year":"2005","journal-title":"J Immunol"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2006.11.017_bib9","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0264-410X(00)00302-9","article-title":"Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine","volume":"19","author":"Roy","year":"2000","journal-title":"Vaccine"},{"issue":"31","key":"10.1016\/j.vaccine.2006.11.017_bib10","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1016\/S0264-410X(03)00447-X","article-title":"Hepatitis B DNA vaccine induces protective antibody responses in human non-responders to conventional vaccination","volume":"21","author":"Rottinghaus","year":"2003","journal-title":"Vaccine"},{"issue":"40","key":"10.1016\/j.vaccine.2006.11.017_bib11","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1016\/j.vaccine.2005.05.026","article-title":"Clinical safety and efficacy of a powdered Hepatitis B nucleic acid vaccine delivered to the epidermis by a commercial prototype device","volume":"23","author":"Roberts","year":"2005","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2006.11.017_bib12","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1016\/j.vaccine.2005.08.012","article-title":"Epidermal DNA vaccine for influenza is immunogenic in humans","volume":"24","author":"Drape","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.11.017_bib13","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.4049\/jimmunol.164.9.4635","article-title":"Increased DNA vaccine delivery and immunogenicity by electroporation in vivo","volume":"164","author":"Widera","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2006.11.017_bib14","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1016\/S0264-410X(02)00269-4","article-title":"Electroporation improves the efficacy of DNA vaccines in large animals","volume":"20","author":"Babiuk","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.11.017_bib15","doi-asserted-by":"crossref","first-page":"8469","DOI":"10.1128\/JVI.75.18.8469-8477.2001","article-title":"DNA vaccination with the Hantaan virus M gene protects hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in rhesus monkeys","volume":"75","author":"Hooper","year":"2001","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2006.11.017_bib16","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1128\/IAI.70.1.292-302.2002","article-title":"DNA vaccine combinations expressing either tissue plasminogen activator signal sequence fusion proteins or ubiquitin-conjugated antigens induce sustained protective immunity in a mouse model of pulmonary tuberculosis","volume":"70","author":"Delogu","year":"2002","journal-title":"Infect Immun"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2006.11.017_bib17","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/S0264-410X(01)00492-3","article-title":"Protective efficacy of a plasmid DNA encoding Japanese encephalitis virus envelope protein fused to tissue plasminogenactivator signal sequences: studies in a murine intracerebral virus challenge model","volume":"20","author":"Ashok","year":"2002","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2006.11.017_bib18","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1128\/IAI.67.9.4780-4786.1999","article-title":"Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences","volume":"67","author":"Li","year":"1999","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2006.11.017_bib19","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.4049\/jimmunol.158.5.2278","article-title":"Different T helper cell types and antibody isotypes generated by saline and gene gun DNA Immunization","volume":"158","author":"Feltquate","year":"1997","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2006.11.017_bib20","doi-asserted-by":"crossref","first-page":"8301","DOI":"10.1128\/JVI.70.12.8301-8309.1996","article-title":"Different roles for CD4+ and DC8+ lymphocytes and macrophage subsets in the control of a generalized virus infection","volume":"70","author":"Karupiah","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2006.11.017_bib21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0167-4781(91)90162-F","article-title":"In vivo electroporation and stable transformation of skin cells of newborn mice by plasmid DNA","volume":"1088","author":"Titomirov","year":"1991","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.vaccine.2006.11.017_bib22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1023\/A:1011026726938","article-title":"Topical gene transfer into rat skin using electroporation","volume":"18","author":"Dujardin","year":"2001","journal-title":"Pharm Res"},{"key":"10.1016\/j.vaccine.2006.11.017_bib23","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.ymthe.2003.09.008","article-title":"Needle-free topical electroporation improves gene expression from plasmids administered in porcine skin","volume":"8","author":"Babiuk","year":"2003","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2006.11.017_bib24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/mthe.2000.0257","article-title":"Cutaneous transfection and immune responses to intradermal nucleic acid vaccination are significantly enhanced by in vivo electropermeabilization","volume":"3","author":"Drabick","year":"2001","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2006.11.017_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-4165(02)00270-2","article-title":"Enhanced delivery of naked DNA to the skin by non-invasive in vivo electroporation","volume":"1572","author":"Zhang","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.vaccine.2006.11.017_bib26","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bioelechem.2003.11.011","article-title":"Enhancement of the effectiveness of electroporation-augmented cutaneous DNA vaccination by a particulate adjuvant","volume":"63","author":"Zhang","year":"2004","journal-title":"Bioelectrochemistry"},{"key":"10.1016\/j.vaccine.2006.11.017_bib27_1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nm0402-415","article-title":"Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery","volume":"8","author":"Mikszta","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2006.11.017_bib27_2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.virol.2005.08.008","article-title":"Identification and preliminary characterization of vaccinia virus (Dryvax) antigens recognized by vaccinia immune globulin","volume":"343","author":"Jones-Trower","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2006.11.017_bib28","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1016\/j.vaccine.2004.02.034","article-title":"Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB\/c mice from a lethal intranasal poxvirus challenge","volume":"22","author":"Pulford","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.11.017_bib29","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1128\/JVI.66.1.386-398.1992","article-title":"Identification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans","volume":"66","author":"Demkowicz","year":"1992","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2006.11.017_bib30","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1128\/JVI.78.19.10230-10237.2004","article-title":"Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions","volume":"78","author":"Fogg","year":"2004","journal-title":"J Virol"},{"issue":"18","key":"10.1016\/j.vaccine.2006.11.017_bib31","doi-asserted-by":"crossref","first-page":"11724","DOI":"10.1128\/JVI.79.18.11724-11733.2005","article-title":"Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice","volume":"79","author":"Davies","year":"2005","journal-title":"J Virol"},{"issue":"13","key":"10.1016\/j.vaccine.2006.11.017_bib32","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1128\/JVI.78.13.7052-7060.2004","article-title":"Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses","volume":"78","author":"Snyder","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2006.11.017_bib33","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1128\/JVI.65.10.5631-5635.1991","article-title":"The purified 14 kilodalton envelope protein of vaccinia virus produced in Escherichia coli induces virus immunity in animals","volume":"65","author":"Lai","year":"1991","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2006.11.017_bib34","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.virol.2005.09.056","article-title":"Immunization with a single extracellular enveloped virus protein produced in bacteria provides partial protection from a lethal orthopoxvirus infection in a natural host","volume":"345","author":"Fang","year":"2006","journal-title":"Virology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06012023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06012023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T21:04:56Z","timestamp":1683666296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06012023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0264410X06012023"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.11.017","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}